Reduces oxidative stress and immune activation Promotes vascular repair in inflamed tissue May help maintain remission alongside standard therapies BPC-157 therapy in colitis models improved mucosal appearance, weight retention, and reduced systemic inflammation markers. Tkalcevic, V
Another storage-protocol guide suggests roughly 30 days (1 month) in the fridge post-mixing
Post-Injury Recovery Studies Due to overlapping properties, BPC-157 and TB-500 are frequently studied together in the context of systemic injury recovery
Research shows the peptide inhibits NFkB activation, a master regulator of inflammatory response
Research-grade peptides, on the other hand, are not intended for use in humans, and their safety cant be guaranteed
Which Peptide Therapy Option Is Right for You